I am a
Home I AM A Search Login

Papers of the Week


2019 Jun


J Dermatol Sci


94


3

Long-term safety and efficacy of rupatadine in Japanese patients with itching due to chronic spontaneous urticaria, dermatitis, or pruritus: A 12-month, multicenter, open-label clinical trial.

Abstract

Rupatadine is a novel H1 antihistamine with platelet-activating factor antagonist activity. Its efficacy and safety on pruritic skin diseases have been demonstrated by 10 mg/day rupatadine in a two weeks clinical trial.